News and updates from across the LGC Group

A new centre of excellence that will support innovation in the medicine, food and drink, and high-value manufacturing sectors has opened in Glasgow

Global leader in Life Sciences Tools sectors sold to Cinven and Astorg

Update for the half year ended 30 September 2019. Management confirms that trading is in line with expectations.

Edan Diagnostics, Inc., a wholly own subsidiary of Edan Instruments, Inc., a world leader in the development and manufacture of bio-electronic devices and laboratory analyzers for medical diagnostics, and LGC, a global life science tools leader, announced today the sale of LGC’s ClariLight molecular diagnostics Point of Care (POC) platform to Edan.

Event focused on analysis of food allergens, their management in the supply chain and regulation and enforcement of food law on allergens.

Hoped that many other organisations will follow in support

VALIDATE UC1 & UC4, for SIEMENS ATELLICA analyzers, addresses the growing demand by laboratories in need of a product to document Urine Chemistry linearity and calibration verification

The book, commissioned following UK horsemeat incident in 2013, provides fundamental understanding of modern DNA techniques applied to food authenticity and adulteration testing.

The addition of VALIDATE® LP2, for the Roche cobas®, offering Apo-A1 and Apo-B, used in conjunction with VALIDATE® LP for HDL and LDL, offers easy, fast, efficient linearity and calibration verification of Lipoproteins

The HD-X has been unveiled at LGC’s GLP/GCP-accredited lab in Fordham

The Government Chemist role was created to help protect the public from fraud, malpractice and harm. As mentioned in its 2018 Annual Review, the Government Chemist team saw an interesting case on pesticides.

LGC announces the acquisition of a majority stake in Toronto Research Chemicals, a leading manufacturer and supplier of synthetic organic bio-chemicals